These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23147755)

  • 21. Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept.
    Tyring S; Bagel J; Lynde C; Klekotka P; Thompson EH; Gandra SR; Shi Y; Kricorian G
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):125-8. PubMed ID: 22188302
    [No Abstract]   [Full Text] [Related]  

  • 22. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L;
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.
    Nosotti L; Francesconi F; Izzi S; Berardesca E; Morrone A; Bonifati C
    Br J Dermatol; 2010 Jun; 162(6):1408-10. PubMed ID: 20184582
    [No Abstract]   [Full Text] [Related]  

  • 24. Etanercept for psoriasis in the pediatric population: experience in nine patients.
    Hawrot AC; Metry DW; Theos AJ; Levy ML
    Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subgroup analyses of etanercept in pediatric patients with psoriasis.
    Paller AS; Eichenfield LF; Langley RG; Leonardi CL; Siegfried EC; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Aug; 63(2):e38-41. PubMed ID: 20633781
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
    Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
    Moore A; Gordon KB; Kang S; Gottlieb A; Freundlich B; Xia HA; Stevens SR
    J Am Acad Dermatol; 2007 Apr; 56(4):598-603. PubMed ID: 17113190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.
    Pariser DM; Leonardi CL; Gordon K; Gottlieb AB; Tyring S; Papp KA; Li J; Baumgartner SW
    J Am Acad Dermatol; 2012 Aug; 67(2):245-56. PubMed ID: 22015149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
    Prestinari F; Ferguglia G; Laria G
    Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.
    Vine K; Votava HJ; Smith BL
    Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: a case report.
    Begini P; Cox MC; Angeletti S; Gigante E; Baccini F; Di Fonzo M; Delle Fave G; Marignani M
    Scand J Infect Dis; 2011 Sep; 43(9):750-2. PubMed ID: 21696249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.
    Griffiths CE; Strober BE; van de Kerkhof P; Ho V; Fidelus-Gort R; Yeilding N; Guzzo C; Xia Y; Zhou B; Li S; Dooley LT; Goldstein NH; Menter A;
    N Engl J Med; 2010 Jan; 362(2):118-28. PubMed ID: 20071701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.
    Lee ES; Heller MM; Kamangar F; Park KK; Koo JY
    J Drugs Dermatol; 2012 Mar; 11(3):413-4. PubMed ID: 22395596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
    Gottlieb A; Feng J; Harrison DJ; Globe D
    J Am Acad Dermatol; 2010 Oct; 63(4):580-6. PubMed ID: 20599294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
    Thayer S; Watson C; Song R; Globe DR; Harrison DJ
    J Med Econ; 2010; 13(2):228-35. PubMed ID: 20459298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term etanercept in pediatric patients with plaque psoriasis.
    Paller AS; Siegfried EC; Eichenfield LF; Pariser D; Langley RG; Creamer K; Kricorian G
    J Am Acad Dermatol; 2010 Nov; 63(5):762-8. PubMed ID: 20605256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 40. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.